BCL2 and neoplasm: Furthermore, in vitro studies of PCa cell lines (from androgen‐insensitive and androgen‐sensitive tumors) have shown that drug‐induced reductions in prostatic inflammation are associated with tumor apoptosis and death through specific mitochondrial pathways involving BCL‐2 [47].